Cover Image
市場調查報告書

平滑肌肉瘤:全球臨床實驗檢討

Leiomyosarcoma Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品編碼 247626
出版日期 內容資訊 英文 147 Pages
訂單完成後即時交付
價格
Back to Top
平滑肌肉瘤:全球臨床實驗檢討 Leiomyosarcoma Global Clinical Trials Review, H2, 2017
出版日期: 2017年11月22日 內容資訊: 英文 147 Pages
簡介

本報告提供平滑肌肉瘤治療藥物的臨床實驗資料,彙整各國的趨勢,臨床實驗數,全球各臨床實驗中心的募集情況等資料,為您概述為以下內容。

目錄

簡介

  • 平滑肌肉瘤
  • 關於本報告

各地區的臨床試驗

  • 臨床試驗:各國
    • 亞太地區前五名國家
    • 歐洲的前五國
    • 北美前幾名國家
    • 中東及非洲的前幾名國家
    • 中南美的主要國家

G7各國的臨床試驗

G7各國的臨床試驗:各臨床實驗狀態

E7各國的臨床試驗

E7各國的臨床試驗:各臨床實驗狀態

Phase別的臨床試驗

  • 進行中的臨床實驗:Phase別

臨床試驗:各臨床實驗狀態

未完成的臨床實驗

每段時期的實驗人數

有力的贊助商

  • 主要參與臨床實驗的企業

潛力治療藥物

臨床試驗簡介

  • 臨床試驗概要:主要企業
    • Sarcoma Alliance for Research through Collaboration
    • Janssen Global Services, LLC
    • Eisai
    • 日本化藥.
    • Merck & Co., Inc.
    • Johnson & Johnson
    • Eli Lilly and Company
    • 第一三強
    • Cell Therapeutics, Inc.
    • ArQule, Inc.
  • 臨床試驗概要:最高級大學 / 研究機關 / 醫院
    • National Cancer Institute
    • Gynecologic Oncology Group
    • European Organization for Research and Treatment of Cancer
    • Memorial Sloan Kettering Cancer Center
    • The University of Texas M. D. Anderson Cancer Center
    • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
    • New York University School of Medicine
    • UNICANCER Group
    • Case Comprehensive Cancer Center

主要臨床實驗5件簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二次調查
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4704CTIDB

GlobalData's clinical trial report, "Leiomyosarcoma Global Clinical Trials Review, H2, 2017" provides an overview of Leiomyosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Leiomyosarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
  • Top Five Countries Contributing to Clinical Trials in Europe 13
  • Top Countries Contributing to Clinical Trials in North America 14
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 15
  • Top Five Countries Contributing to Clinical Trials in Central and South America 16
  • Clinical Trials by G7 Countries: Proportion of Leiomyosarcoma to Oncology Clinical Trials 17
  • Clinical Trials by Phase in G7 Countries 18
  • Clinical Trials in G7 Countries by Trial Status 19
  • Clinical Trials by E7 Countries: Proportion of Leiomyosarcoma to Oncology Clinical Trials 21
  • Clinical Trials by Phase in E7 Countries 22
  • Clinical Trials in E7 Countries by Trial Status 23
  • Clinical Trials by Phase 24
  • In Progress Trials by Phase 25
  • Clinical Trials by Trial Status 26
  • Clinical Trials by End Point Status 28
  • Subjects Recruited Over a Period of Time 29
  • Clinical Trials by Sponsor Type 30
  • Prominent Sponsors 31
  • Top Companies Participating in Leiomyosarcoma Therapeutics Clinical Trials 33
  • Prominent Drugs 35
  • Latest Clinical Trials News on Leiomyosarcoma 36
  • Nov 13, 2017: PharmaMar Presents Update on YONDELIS at CTOS 36
  • Nov 03, 2017: PharmaMar will present at ESGO new data on Yondelis for gynecological cancers 36
  • Aug 31, 2017: PharmaMar will Present Clinical Data of Yondelis During ESMO 2017 37
  • Clinical Trial Profile Snapshots 38

Appendix 168

  • Abbreviations 168
  • Definitions 168
  • Research Methodology 169
  • Secondary Research 169
  • About GlobalData 170
  • Contact Us 170
  • Disclaimer 170
  • Source 171

List of Tables

List of Tables

  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Region, 2017* 8
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
  • Leiomyosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 12
  • Leiomyosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 13
  • Leiomyosarcoma Therapeutics Clinical Trials, North America, Top Countries, 2017* 14
  • Leiomyosarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 15
  • Leiomyosarcoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 16
  • Proportion of Leiomyosarcoma to Oncology Clinical Trials, G7 Countries (%), 2017* 17
  • Leiomyosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
  • Leiomyosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Proportion of Leiomyosarcoma to Oncology Clinical Trials, E7 Countries (%), 2017* 21
  • Leiomyosarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
  • Leiomyosarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Phase, 2017* 24
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 25
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 26
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 28
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 29
  • Leiomyosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 30
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 31
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 33
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 35

List of Figures

List of Figures

  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
  • Leiomyosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 12
  • Leiomyosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 13
  • Leiomyosarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 14
  • Leiomyosarcoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 16
  • Proportion of Leiomyosarcoma to Oncology Clinical Trials, G7 Countries (%), 2017* 17
  • Leiomyosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
  • Leiomyosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Proportion of Leiomyosarcoma to Oncology Clinical Trials, E7 Countries (%), 2017* 21
  • Leiomyosarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
  • Leiomyosarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2017* 24
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 25
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 26
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 28
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 29
  • Leiomyosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 30
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 31
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 33
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 35
  • GlobalData Methodology 169
Back to Top